StockNews.com Downgrades China Pharma (NYSE:CPHI) to Sell

China Pharma (NYSE:CPHI) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Tuesday.

China Pharma Trading Up 5.7%

Shares of China Pharma stock opened at $2.22 on Tuesday. The company’s fifty day simple moving average is $13.28 and its 200-day simple moving average is $18.35. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. China Pharma has a 1 year low of $1.20 and a 1 year high of $4.10.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.